What AI says about Cofactor Genomics
Cofactor Genomics develops diagnostic tools that utilize RNA analysis to predict how cancer patients will respond to immunotherapy. The company partners with healthcare systems to conduct clinical trials for various solid tumor cancers to support precision medicine and clinical decision-making.
AI named Cofactor Genomics in June 2026.
Questions and answers
Competitors
AI named Cofactor Genomics alongside Artera, Ataraxis AI, and EarlyDiagnostics.
Sources AI cites
None of these answers cited cofactorgenomics.com. AI leaned on medicalstartups.org, sbir.cancer.gov, and startus-insights.com.
cofactorgenomics.com 0%Other sites 100%
